Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
09/2003
09/25/2003CA2479266A1 Azetidine derivatives as ccr-3 receptor antagonists
09/25/2003CA2479249A1 Neuroprotective spirostenol pharmaceutical compositions
09/25/2003CA2479246A1 Method for overexpression of zwitterionic polysaccharides
09/25/2003CA2479222A1 Use of selective ep4 receptor agonists for the treatment of liver failure, loss of patency of the ductus arteriosus, glaucoma or ocular hypertension
09/25/2003CA2479212A1 Central airway administration for systemic delivery of therapeutics
09/25/2003CA2479211A1 9-dexo-9a-aza-9a-methyl-9a-homoerythromycin a derivatives
09/25/2003CA2479187A1 Immunostimulatory double stranded rna and methods of inducing, enhancing or modulating the immune response
09/25/2003CA2479151A1 Use of proton pump inhibitors for the treatment of noncardiac chest pain
09/25/2003CA2479141A1 Pyridone derivatives
09/25/2003CA2479140A1 Process for preparing crystalline form i of cabergoline
09/25/2003CA2479098A1 Methods and compositions comprising nitric oxide donors and opioid analgesics
09/25/2003CA2479069A1 Hetero-bridge substituted 8-arylquinoline pde4 inhibitors
09/25/2003CA2478997A1 Use of copper chelating tetraamines for the treatment of cardiovascular disease and heart failure
09/25/2003CA2478965A1 Agents for corneal or intrastromal administration to treat or prevent disorders of the eye
09/25/2003CA2478909A1 Substituted tetrahydroisoquinoline compounds, methods of making, and their use
09/25/2003CA2478867A1 Formulations of anthraquinone derivatives
09/25/2003CA2478808A1 Use of asc-1 inhibitors to treat neurological and psychiatric disorders
09/25/2003CA2478795A1 Use of rapamycin for inhibiting cell death
09/25/2003CA2478760A1 Use of enzyme inhibitors with aminopeptidase n and/or dipeptidylpeptidase iv activities and pharmaceutical preparations produced therefrom for the therapy and prevention of dermatological diseases with seborrhoeic hyperproliferation and altered differentiation states
09/25/2003CA2478758A1 Pharmaceutical compositions comprising 2-(4-ethoxy-phenyl)-3-(4-methanesulfonyl-phenyl)-pyrazolo'1,5-bipyridazine in nanoparticulate form
09/25/2003CA2478731A1 Carbamates as hiv protease inhibitors
09/25/2003CA2478715A1 Novel pyrazolo [1,5-a]pyridine derivatives and their use as neurotransmitter modulators
09/25/2003CA2478713A1 Non-peptide gnrh antagonists
09/25/2003CA2478653A1 Methods of treatment with selective ep4 receptor agonists
09/25/2003CA2478540A1 Indazoles substituted with an anti-cancerous activity
09/25/2003CA2478534A1 N3 alkylated benzimidazole derivatives as mek inhibitors
09/25/2003CA2478500A1 Crystalline parecoxib sodium
09/25/2003CA2478336A1 Extended cycle estrogen and sulfatase inhibiting progestogen contraceptive regimens
09/25/2003CA2478331A1 Peptide deformylase inhibitors
09/25/2003CA2478310A1 N-(substituted benzyl)-8-hydroxy-1,6-naphthyridine-7-carboxamides useful as hiv integrase inhibitors
09/25/2003CA2478248A1 Methods and devices for detection and therapy of atheromatous plaque
09/25/2003CA2478211A1 Nk1 antagonists
09/25/2003CA2478206A1 Sulfatase inhibiting continuous progestogen contraceptive regimens
09/25/2003CA2478194A1 Continuous sulfatase inhibiting progestogen hormone replacement therapy
09/25/2003CA2478184A1 Drug combination therapy
09/25/2003CA2478165A1 Sulfatase inhibiting progestogen-only contraceptive regimens
09/25/2003CA2478074A1 Percutaneous absorption promoters and compositions for treating athlete's foot
09/25/2003CA2478048A1 Novel florfenicol-type antibiotics
09/25/2003CA2477909A1 Novel metabolic targets and markers
09/25/2003CA2477832A1 Methods of treating diabetes using pde 11a inhibitors
09/25/2003CA2477732A1 Aminomethyl-substituted thiazolobenzimidazole derivatives
09/25/2003CA2476908A1 Composition comprising an l-ascorbic acid and an organic base for treatment of ocular disorders
09/25/2003CA2476906A1 Compositions for treating diabetes
09/25/2003CA2476746A1 Difurylglycolic acid tropenol esters used as anticholinesterase drugs
09/25/2003CA2459836A1 Oligo(ethylene glycol)-terminated 1,2-dithiolanes and their conjugates useful for preparing self-assembled monolayers
09/24/2003EP1347059A1 Cathepsin Y for the development of a medicament for the treatment of stroke
09/24/2003EP1347055A2 Compounds for immunotherapy and diagnosis of tuberculosis
09/24/2003EP1346993A1 Lactam compounds and medicinal use thereof
09/24/2003EP1346992A1 Quinazoline derivatives, process for their preparation and pharmaceutical compositions containing them
09/24/2003EP1346987A1 Benzofuran derivatives and pharmaceutical compositions containing the same
09/24/2003EP1346745A1 Apparatus for treatment of tumor in the central nervous system (CNS)
09/24/2003EP1346732A2 Dosage forms for hygroscopic active ingredients
09/24/2003EP1346731A1 Conjugates for treating inflammatory disorders and associated tissue damage
09/24/2003EP1346728A1 Ophthalmological preparations
09/24/2003EP1346726A1 Sympathetic-activating perfume composition
09/24/2003EP1346725A1 Pharmaceutical composition comprising PIM-activated NKT cells, and therapeutic use thereof
09/24/2003EP1346724A1 Remedies for hepatitis c
09/24/2003EP1346723A1 Multiparticulate enteric coated and multiparticulate enteric coated prolonged release formulations containing NADH
09/24/2003EP1346722A1 Method for producing preparation containing bioactive substance
09/24/2003EP1346218A1 Tripeptide of fc gama riia
09/24/2003EP1346065A2 Antisense modulation of src-2 expression
09/24/2003EP1346061A2 Pregnancy-associated plasma protein-a2 (papp-a2)
09/24/2003EP1346059A1 Photochemical internalization for delivery of molecules into the cytosol
09/24/2003EP1346058A2 Adenoviral systems and the uses thereof
09/24/2003EP1346045A1 Human protooncogene and protein encoded therein
09/24/2003EP1346042A2 Fat regulated genes, uses thereof, and compounds for modulating same
09/24/2003EP1346032A2 Method for the production of carbohydrates
09/24/2003EP1345965A2 Methods and materials relating to stem cell growth factor-like polypeptides and polynucleotides
09/24/2003EP1345961A2 Antigenic ck-18 compounds for therapy and diagnosis and methods for using same
09/24/2003EP1345956A2 Intracellular delivery of biological effectors by novel transporter peptide sequences
09/24/2003EP1345954A2 Methods utilizing aryl thioimines in synthesis of erythromycin derivatives
09/24/2003EP1345953A2 Ketolide antibacterials
09/24/2003EP1345951A1 A substance or composition for the treatment of cancer
09/24/2003EP1345950A2 Inositol derivatives for increasing chloride secretion and inhibiting inflammation
09/24/2003EP1345946A1 Macroheterocylic compounds useful as kinase inhibitors
09/24/2003EP1345945A1 Streptogramin derivatives, preparation thereof and compositions containing same
09/24/2003EP1345944A1 Process for the isolation and purification of epothilones
09/24/2003EP1345943A2 Inhibitors of papilloma virus
09/24/2003EP1345942A2 Pyrazinoquinoxaline derivatives as serotonin agonists and antagonists
09/24/2003EP1345941A1 Cyclin-dependent kinase (cdk) and glycolene synthase kinase-3 (gsk-3) inhibitors
09/24/2003EP1345938A1 Tricyclic crf receptor antagonists
09/24/2003EP1345937A1 Quinuclidine carbamate derivatives and their use as m3 antagonists
09/24/2003EP1345936A1 Method for producing the anticholinergic agent tiotropium bromide
09/24/2003EP1345935A2 Piperidine derivatives as subtype selective n-methyl-d-aspartate antagonists
09/24/2003EP1345933A2 Process for making substituted 8-arylquinolinium benzenesulfonate
09/24/2003EP1345932A1 Diphenyl azetidinone derivatives, method for the production thereof, medicaments containing these compounds, and their use
09/24/2003EP1345931A2 Cysteine protease inhibitors
09/24/2003EP1345930A2 Pharmaceutical compounds
09/24/2003EP1345929A2 Pyrazole compounds useful as protein kinase inhibitors
09/24/2003EP1345928A2 Pyrazole compounds useful as protein kinase inhibitors
09/24/2003EP1345927A1 Pyrazole compounds useful as protein kinase inhibitors
09/24/2003EP1345926A2 Pyrazole compounds useful as protein kinase inhibitors
09/24/2003EP1345925A2 Pyrazole compounds useful as protein kinase inhibitors
09/24/2003EP1345924A1 Diphenyl azetidinone derivatives, method for the production thereof, medicaments containing these compounds, and their use
09/24/2003EP1345922A1 Pyrazole compounds useful as protein kinase inhibitors
09/24/2003EP1345921A1 3-indoline derivatives useful in the treatment of psychiatric and neurologic disorders
09/24/2003EP1345920A1 Novel sulfamides and their use as endothelin receptor antagonists
09/24/2003EP1345919A2 Novel c-glycoside derivatives and use thereof
09/24/2003EP1345918A1 Chemical compounds
09/24/2003EP1345917A1 2-(2-(4-((2r)-2-methyl-3-(10h-phenothiazin-10-yl)propyl)-1-piperazinyl)-ethoxy)ethanol, process for the preparation thereof, pharmaceutical compositions containing said compound and therapeutic uses thereof
1 ... 5332 5333 5334 5335 5336 5337 5338 5339 5340 5341 5342 5343 5344 5345 5346 5347 5348 5349 5350 5351 5352 ... 7860